Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

about

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

Item

http://www.wikidata.org/entity/Q50792998

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

@en

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

@nl

type

Item

label

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

@en

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

@nl

prefLabel

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

@en

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

@nl

P1476

Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.

@en

P2093

A Konar

http://www.w3.org/2001/XMLSchema#string

B N M K Khanum

http://www.w3.org/2001/XMLSchema#string

R Guha

http://www.w3.org/2001/XMLSchema#string

S Hazra

http://www.w3.org/2001/XMLSchema#string

S K Basak

http://www.w3.org/2001/XMLSchema#string

S Nandi

http://www.w3.org/2001/XMLSchema#string

P2860

Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery

Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis

Proliferative vitreoretinopathy: current and emerging treatments

Outcome after silicone oil removal

Pirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burn

Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.

Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.

Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.

Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.

P2888

eye.2017.21

P304

1317-1328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2017.21

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vishma Pratap Sur

P577

2017-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084128028

http://www.w3.org/2001/XMLSchema#string

P698

28304388

http://www.w3.org/2001/XMLSchema#string

P932

5601446

http://www.w3.org/2001/XMLSchema#string